dihexa hgf c-met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF-c-Met Axis in Head – Anti-cancer therapeutic strategies based on
Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link Role of the HGF c MET tyrosine kinase inhibitors in metastasic melanoma Molecular Cancer Springer Nature Link dihexa cancer risk hgf c met Targeting the HGF c MET pathway in advanced pancreatic cancer dihexa hgf c met mechanism Activated HGF c Met Axis in Head and Neck Cancer Targeting HGF c MET signaling to regulate The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




